Published in Immunology on January 01, 2001
Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. Mol Cell (2011) 1.48
Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters. BMC Complement Altern Med (2011) 1.22
Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1beta. Dig Dis Sci (2006) 0.85
Mucosal adjuvant properties of the Shigella invasin complex. Infect Immun (2006) 0.85
Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant. Infect Immun (2004) 0.85
Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2. Immunology (2002) 0.80
Expression of functional hexahistidine-tagged ricin B in tobacco. Plant Cell Rep (2004) 0.79
Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A. PLoS One (2015) 0.77
Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol (1984) 3.89
The role of nasopharyngeal lymphoid tissue. Immunol Today (1992) 3.19
Identification of intact peanut lectin in peripheral venous blood. Lancet (1998) 3.11
Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine (1988) 3.00
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci U S A (1995) 2.63
Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect Immun (1988) 2.32
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun (1996) 2.14
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun (1991) 2.14
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microbiol (1994) 1.75
Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci U S A (1996) 1.73
Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol Today (1999) 1.72
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med (1988) 1.63
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect Immun (1997) 1.54
The mechanism of cholera toxin adjuvanticity. Res Immunol (1998) 1.51
The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol (1991) 1.51
Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol (1994) 1.34
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect Immun (1995) 1.29
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun (1999) 1.20
Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res (1990) 1.11
Genetic control of the murine immune response to cholera toxin. J Immunol (1985) 1.08
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun (1997) 1.02
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment. Vaccine (1995) 1.01
Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches. J Infect Dis (1996) 1.01
Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses. Immunology (1998) 0.99
Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res (1995) 0.98
Dietary lectins can induce in vitro release of IL-4 and IL-13 from human basophils. Eur J Immunol (1999) 0.97
Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur J Biochem (1999) 0.95
Suppression of antibody production by phytohaemagglutinin. Nature (1967) 0.90
Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Deliv Rev (1998) 0.89
The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst (1998) 0.89
Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens. Infect Immun (1999) 0.89
Mucosal immunogenicity of plant lectins in mice. Immunology (2000) 0.88
Lectin-induced modulation of the antibody response to type III pneumococcal polysaccharide. Cell Immunol (1984) 0.86
The effect of phytohaemagglutinin at different dietary concentrations on the growth, body composition and plasma insulin of the rat. Br J Nutr (1996) 0.84
Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose. J Mol Biol (1993) 0.76
Effect of diets containing genetically modified potatoes expressing Galanthus nivalis lectin on rat small intestine. Lancet (1999) 6.74
Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J (1978) 3.20
Environmental injustice in North Carolina's hog industry. Environ Health Perspect (2000) 2.22
Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology (1972) 2.09
Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res (1990) 2.07
The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol (1984) 1.94
Readability and content of supplementary written drug information for patients used by Australian rheumatologists. Med J Aust (2001) 1.67
The immunological responsiveness of germ-free mice thymectomized at birth. I. Antibody production and skin homograft rejection. Clin Exp Immunol (1967) 1.66
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res (1993) 1.53
The preoperative assessment of the corneal endothelium. Aust N Z J Ophthalmol (1988) 1.52
Human minisatellites, repeat DNA instability and meiotic recombination. Electrophoresis (1999) 1.48
Fractionation and characterization of glycoproteins containing hydroxyproline from the leaves of Vicia faba. Eur J Biochem (1969) 1.37
Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors. Digestion (1990) 1.28
Mass discharges evoked in the olivocerebellar tract on stimulation of muscle and skin nerves. Exp Brain Res (1966) 1.20
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 1.19
Glycoprotein II. The isolation and characterization of a major antigenic and non-haemagglutinating glycoprotein from Phaseolus vulgaris. Biochim Biophys Acta (1970) 1.19
Oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther (2003) 1.18
The nutritional toxicity of Phaseolus vulgaris lectins. Proc Nutr Soc (1979) 1.15
HIV and mucosal immunity. Lancet (1991) 1.14
The importance of dietary polyamines in cell regeneration and growth. Br J Nutr (1995) 1.14
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.13
Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience (1994) 1.10
Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horseradish peroxidase in the rat. Neuroscience (1986) 1.10
Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins. Br J Nutr (1993) 1.09
Regeneration of thymus grafts. II. Effects on immunological capacity. Clin Exp Immunol (1966) 1.08
Isolectins of Phaseolus vulgaris. A comprehensive study of fractionation. Biochim Biophys Acta (1974) 1.07
Impact of odor from industrial hog operations on daily living activities. New Solut (2008) 1.07
Role of different sensory inputs for maintenance of body posture in sitting rat and rabbit. Motor Control (2000) 1.06
Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J Drug Target (1993) 1.04
Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial. Lancet (1982) 1.04
Tolerance of the eye for implanted cilia. Br J Ophthalmol (1991) 1.04
Interactions of proteins with other polyelectrolytes in a two-phase system containing phenol and aqueous buffers at various pH values. Biochem J (1966) 1.03
Biochemical, molecular and behavioral phenotypes of Rab3A mutations in the mouse. Genes Brain Behav (2007) 1.02
Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA. Pharm Res (2001) 1.02
Immunogold localization of ingested kidney bean (Phaseolus vulgaris) lectins in epithelial cells of the rat small intestine. Histochem J (1986) 1.02
Targeting of drugs and vaccines to the gut. Pharmacol Ther (1995) 1.02
Interferon-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J Neurocytol (1998) 1.02
Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol (1984) 1.02
Cytoarchitectonic organization of the spinal cord in the rat: II. The cervical and upper thoracic cord. J Comp Neurol (1989) 1.01
Pseudomonas aeruginosa II lectin stops human ciliary beating: therapeutic implications of fucose. Am J Respir Crit Care Med (1997) 1.01
Studies in immunochemistry. 23. Some observations on the heterogeneity of preparations of human blood-group-specific substances. Biochem J (1964) 1.01
A comparison between wheat germ agglutinin-and choleragenoid-horseradish peroxidase as anterogradely transported markers in central branches of primary sensory neurones in the rat with some observations in the cat. Neuroscience (1985) 1.00
Increased uptake and transport of cholera toxin B-subunit in dorsal root ganglion neurons after peripheral axotomy: possible implications for sensory sprouting. J Comp Neurol (1999) 1.00
The reaction of primary sensory neurons to peripheral nerve injury with particular emphasis on transganglionic changes. Brain Res (1985) 0.99
Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses. Immunology (1998) 0.99
Comparison of specular microscopy and examination of aspirate in phacolytic glaucoma. Ophthalmology (1990) 0.99
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine (1995) 0.98
Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett (1996) 0.98
Thermal treatment improves nutritional quality of pea seeds (Pisum sativum L.) without reducing their hypocholesterolemic properties. Nutr Res (2001) 0.98
A survey of the nutritional and haemagglutination properties of legume seeds generally available in the UK. Br J Nutr (1983) 0.98
Functional organization of the spinoreticulocerebellar path with identification of its spinal component. Exp Brain Res (1966) 0.97
The determination of the molecular size of peptides and proteins by chromatography on bio gel P-100 columns in phenol-acetic acid-water (1:1:1,W-V-V) solvent mixture. Biochim Biophys Acta (1970) 0.97
Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. Neuroreport (1997) 0.96
A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J Control Release (2001) 0.96
Reversible effect of phytohaemagglutinin on the growth and metabolism of rat gastrointestinal tract. Gut (1995) 0.96
Antimicrobial activity of selected cyclic dipeptides. Pharmazie (1999) 0.96
Kidney bean (Phaseolus vulgaris) lectin-induced lesions in the small intestine: 1. Light microscope studies. J Comp Pathol (1980) 0.95
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. Vaccine (1995) 0.95
Luminal and basolateral polyamine uptake by rat small intestine stimulated to grow by Phaseolus vulgaris lectin phytohaemagglutinin in vivo. Biochim Biophys Acta (1990) 0.95
The toxicity of Phaseolus vulgaris lectins. Nitrogen balance and immunochemical studies. J Sci Food Agric (1981) 0.94
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology (1994) 0.94
The properties of bovine serum albumin and chymotrypsinogen A in solvent mixtures containing phenol. Biochem J (1966) 0.94
Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine. J Immunol (2001) 0.93
A disattenuated correlation estimate when variables are measured with error: illustration estimating cross-platform correlations. Stat Med (2008) 0.93
Expression of mRNAs for neurotrophin receptors in the dorsal root ganglion and spinal cord during development and following peripheral or central axotomy. Brain Res Mol Brain Res (1993) 0.93
Immunocytochemical localization of ingested kidney bean (Phaseolus vulgaris) lectins in rat gut. Histochem J (1980) 0.92
The isolation of two proteins, glycoprotein I and a trypsin inhibitor, from the seeds of kidney bean (Phaseolus vulgaris). Biochem J (1966) 0.92
Salmonella enterica var Typhimurium and Salmonella enterica var Enteritidis express type 1 fimbriae in the rat in vivo. FEMS Immunol Med Microbiol (1997) 0.92
Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Release (2000) 0.92
Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res (1994) 0.92
Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv (2006) 0.92
Transganglionic transport of horseradish peroxidase in primary sensory neurons. Neurosci Lett (1979) 0.92
Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo. Exp Physiol (2005) 0.92
Changing pattern of c-FOS expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat. Neuroscience (1992) 0.91
Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin. FEMS Microbiol Lett (1993) 0.91
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. Am J Med (1989) 0.91
Kidney bean (Phaseolus vulgaris) lectin-induced lesions in rat small intestine. 3. Ultrastructural studies. J Comp Pathol (1982) 0.91
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood (1988) 0.91
Nutritional evaluation of kidney beans (Phaseolus vulgaris): chemical composition, lectin content and nutritional value of selected cultivars. J Sci Food Agric (1979) 0.91
Lectins and also bacteria modify the glycosylation of gut surface receptors in the rat. Glycoconj J (1995) 0.91
Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model. Br J Cancer (2007) 0.91
Microparticles for intranasal immunization. Adv Drug Deliv Rev (2001) 0.90
The nutrition evaluation of kidney beans (Phaseolus vulgaris). The effect of nutritional value of seed germination and changes in trypsin inhibitor content. J Sci Food Agric (1973) 0.90
Adhesion of Salmonella enterica var Enteritidis strains lacking fimbriae and flagella to rat ileal explants cultured at the air interface or submerged in tissue culture medium. J Med Microbiol (2000) 0.90
Orientation restrictions of the peptide hormone, thyrotropin-releasing factor, due to intramolecular hydrogen bonding. Biochemistry (1972) 0.90
The role of tonic vestibular input for postural control in rats. Arch Ital Biol (1997) 0.90
Differentiation and assessment of corneal endothelial changes associated with diseases of the anterior segment of the eye. Aust N Z J Ophthalmol (1987) 0.90
Asymmetries and symmetries in the number of thoracic dorsal root ganglion cells. J Comp Neurol (1981) 0.89
Effect of neonatal thymectomy on the induction of papillomata and carcinoma by 3,4-benzopyrene in mice. Nature (1966) 0.89
Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization. Infect Immun (1999) 0.89